Tesamorelin

from $77.50

Tesamorelin — Growth Hormone & Metabolic Signaling Research

A synthetic growth hormone-releasing hormone (GHRH) analog centered around the biology of pituitary signaling, growth hormone secretion, body-composition physiology, and metabolic communication, with particular interest in the pathways connecting GHRH signaling with the GH/IGF-1 axis.

Tesamorelin is a stabilized analog of human GHRH that activates GHRH receptors on pituitary somatotroph cells, stimulating endogenous growth hormone secretion and downstream IGF-1 signaling. Research has examined its effects on GH/IGF-1 physiology, adipose-tissue metabolism, body composition, and metabolic signaling. Unlike many research compounds in this library, tesamorelin is an FDA-approved prescription medication for reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy; it is not indicated for general weight-loss management.

Research Focus: GHRH Receptor Signaling • Growth Hormone Physiology • GH/IGF-1 Axis • Pituitary Function • Adipose-Tissue Biology • Body-Composition Research • Metabolic Signaling

A GHRH-based peptide for those interested in the science of pituitary communication, endogenous growth hormone signaling, adipose-tissue biology, and the metabolic pathways associated with the GH/IGF-1 axis.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.

MG:

Tesamorelin — Growth Hormone & Metabolic Signaling Research

A synthetic growth hormone-releasing hormone (GHRH) analog centered around the biology of pituitary signaling, growth hormone secretion, body-composition physiology, and metabolic communication, with particular interest in the pathways connecting GHRH signaling with the GH/IGF-1 axis.

Tesamorelin is a stabilized analog of human GHRH that activates GHRH receptors on pituitary somatotroph cells, stimulating endogenous growth hormone secretion and downstream IGF-1 signaling. Research has examined its effects on GH/IGF-1 physiology, adipose-tissue metabolism, body composition, and metabolic signaling. Unlike many research compounds in this library, tesamorelin is an FDA-approved prescription medication for reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy; it is not indicated for general weight-loss management.

Research Focus: GHRH Receptor Signaling • Growth Hormone Physiology • GH/IGF-1 Axis • Pituitary Function • Adipose-Tissue Biology • Body-Composition Research • Metabolic Signaling

A GHRH-based peptide for those interested in the science of pituitary communication, endogenous growth hormone signaling, adipose-tissue biology, and the metabolic pathways associated with the GH/IGF-1 axis.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.

These products are designated solely for research purposes only and is not intended for human consumption. These products are expressly tailored for laboratory inquiries, comprising both in vitro assessments and in vivo animal experiments, to be conducted exclusively by trained professionals. Compliance with all relevant regulations and directives is essential in the handling and deployment of these items. By acquiring these goods, you commit to their utilization strictly in conformity with prevailing regulations and solely for legitimate research purposes. Any unauthorized or improper usage of these products is explicitly prohibited.